| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Fusion Protein:ALB-EXOSC9 |
Fusion Protein Summary |
 Fusion gene summary |
| Fusion partner gene information | Fusion gene name: ALB-EXOSC9 | FusionPDB ID: 3750 | FusionGDB2.0 ID: 3750 | Hgene | Tgene | Gene symbol | ALB | EXOSC9 | Gene ID | 213 | 5393 |
| Gene name | albumin | exosome component 9 | |
| Synonyms | HSA|PRO0883|PRO0903|PRO1341 | PCH1D|PM/Scl-75|PMSCL1|RRP45|Rrp45p|p5|p6 | |
| Cytomap | 4q13.3 | 4q27 | |
| Type of gene | protein-coding | protein-coding | |
| Description | serum albumin | exosome complex component RRP45P75 polymyositis-scleroderma overlap syndrome associated autoantigenPMSCL autoantigen, 75kDautoantigen PM/Scl 1exosome complex exonuclease RRP45polymyositis/scleroderma autoantigen 1, 75kDa | |
| Modification date | 20200329 | 20200320 | |
| UniProtAcc | P02768 | Q06265 | |
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000295897, ENST00000401494, ENST00000415165, ENST00000509063, ENST00000503124, ENST00000505649, | ENST00000379663, ENST00000509980, ENST00000512454, ENST00000243498, |
| Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 66 X 51 X 5=16830 | 8 X 8 X 4=256 |
| # samples | 74 | 8 | |
| ** MAII score | log2(74/16830*10)=-4.507366095701 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/256*10)=-1.67807190511264 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context (manual curation of fusion genes in FusionPDB) | PubMed: ALB [Title/Abstract] AND EXOSC9 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ALB(74270123)-EXOSC9(122737927), # samples:4 | ||
| Anticipated loss of major functional domain due to fusion event. | ALB-EXOSC9 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ALB-EXOSC9 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | ALB | GO:0009267 | cellular response to starvation | 16245148 |
| Hgene | ALB | GO:0043066 | negative regulation of apoptotic process | 16153637 |
| Hgene | ALB | GO:0051659 | maintenance of mitochondrion location | 16153637 |
| Fusion gene breakpoints across ALB (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across EXOSC9 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
Top |
Fusion Gene Sample Information |
| Fusion gene information from FusionGDB2.0. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | KIRP | TCGA-SX-A7SS-01A | ALB | chr4 | 74270123 | - | EXOSC9 | chr4 | 122737927 | + |
| ChimerDB4 | KIRP | TCGA-SX-A7SS | ALB | chr4 | 74270123 | + | EXOSC9 | chr4 | 122737927 | + |
| ChimerDB4 | LIHC | TCGA-XR-A8TG-01A | ALB | chr4 | 74270123 | - | EXOSC9 | chr4 | 122737927 | + |
| ChimerDB4 | LIHC | TCGA-XR-A8TG-01A | ALB | chr4 | 74270123 | + | EXOSC9 | chr4 | 122737927 | + |
Top |
Fusion ORF Analysis |
| Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000295897 | ALB | chr4 | 74270123 | + | ENST00000243498 | EXOSC9 | chr4 | 122737927 | + | 306 | 168 | 62 | 220 | 52 |
| ENST00000415165 | ALB | chr4 | 74270123 | + | ENST00000243498 | EXOSC9 | chr4 | 122737927 | + | 258 | 120 | 14 | 172 | 52 |
| ENST00000509063 | ALB | chr4 | 74270123 | + | ENST00000243498 | EXOSC9 | chr4 | 122737927 | + | 241 | 103 | 152 | 0 | 51 |
| ENST00000401494 | ALB | chr4 | 74270123 | + | ENST00000243498 | EXOSC9 | chr4 | 122737927 | + | 237 | 99 | 148 | 2 | 49 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000295897 | ENST00000243498 | ALB | chr4 | 74270123 | + | EXOSC9 | chr4 | 122737927 | + | 0.92129326 | 0.078706734 |
| ENST00000415165 | ENST00000243498 | ALB | chr4 | 74270123 | + | EXOSC9 | chr4 | 122737927 | + | 0.952157 | 0.047842976 |
| ENST00000509063 | ENST00000243498 | ALB | chr4 | 74270123 | + | EXOSC9 | chr4 | 122737927 | + | 0.95388025 | 0.04611975 |
| ENST00000401494 | ENST00000243498 | ALB | chr4 | 74270123 | + | EXOSC9 | chr4 | 122737927 | + | 0.9602725 | 0.039727494 |
Top |
Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >3750_3750_1_ALB-EXOSC9_ALB_chr4_74270123_ENST00000295897_EXOSC9_chr4_122737927_ENST00000243498_length(amino acids)=52AA_BP=36 -------------------------------------------------------------- >3750_3750_2_ALB-EXOSC9_ALB_chr4_74270123_ENST00000401494_EXOSC9_chr4_122737927_ENST00000243498_length(amino acids)=49AA_BP=1 -------------------------------------------------------------- >3750_3750_3_ALB-EXOSC9_ALB_chr4_74270123_ENST00000415165_EXOSC9_chr4_122737927_ENST00000243498_length(amino acids)=52AA_BP=36 -------------------------------------------------------------- >3750_3750_4_ALB-EXOSC9_ALB_chr4_74270123_ENST00000509063_EXOSC9_chr4_122737927_ENST00000243498_length(amino acids)=51AA_BP=1 -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr4:74270123/chr4:122737927) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ALB | EXOSC9 |
| FUNCTION: Binds water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs (Probable). Its main function is the regulation of the colloidal osmotic pressure of blood (Probable). Major zinc transporter in plasma, typically binds about 80% of all plasma zinc (PubMed:19021548). Major calcium and magnesium transporter in plasma, binds approximately 45% of circulating calcium and magnesium in plasma (By similarity). Potentially has more than two calcium-binding sites and might additionally bind calcium in a non-specific manner (By similarity). The shared binding site between zinc and calcium at residue Asp-273 suggests a crosstalk between zinc and calcium transport in the blood (By similarity). The rank order of affinity is zinc > calcium > magnesium (By similarity). Binds to the bacterial siderophore enterobactin and inhibits enterobactin-mediated iron uptake of E.coli from ferric transferrin, and may thereby limit the utilization of iron and growth of enteric bacteria such as E.coli (PubMed:6234017). Does not prevent iron uptake by the bacterial siderophore aerobactin (PubMed:6234017). {ECO:0000250|UniProtKB:P02769, ECO:0000269|PubMed:19021548, ECO:0000269|PubMed:6234017, ECO:0000305|PubMed:1630489}. | FUNCTION: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC9 binds to ARE-containing RNAs. {ECO:0000269|PubMed:11782436, ECO:0000269|PubMed:16455498, ECO:0000269|PubMed:16912217, ECO:0000269|PubMed:17545563}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - Not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | ALB | chr4:74270123 | chr4:122737927 | ENST00000295897 | + | 1 | 15 | 19_210 | 26.333333333333332 | 661.0 | Domain | Albumin 1 |
| Hgene | ALB | chr4:74270123 | chr4:122737927 | ENST00000295897 | + | 1 | 15 | 211_403 | 26.333333333333332 | 661.0 | Domain | Albumin 2 |
| Hgene | ALB | chr4:74270123 | chr4:122737927 | ENST00000295897 | + | 1 | 15 | 404_601 | 26.333333333333332 | 661.0 | Domain | Albumin 3 |
| Hgene | ALB | chr4:74270123 | chr4:122737927 | ENST00000509063 | + | 1 | 14 | 19_210 | 26.333333333333332 | 605.0 | Domain | Albumin 1 |
| Hgene | ALB | chr4:74270123 | chr4:122737927 | ENST00000509063 | + | 1 | 14 | 211_403 | 26.333333333333332 | 605.0 | Domain | Albumin 2 |
| Hgene | ALB | chr4:74270123 | chr4:122737927 | ENST00000509063 | + | 1 | 14 | 404_601 | 26.333333333333332 | 605.0 | Domain | Albumin 3 |
| Tgene | EXOSC9 | chr4:74270123 | chr4:122737927 | ENST00000243498 | 10 | 12 | 1_268 | 411.6666666666667 | 440.0 | Region | ARE binding | |
| Tgene | EXOSC9 | chr4:74270123 | chr4:122737927 | ENST00000379663 | 11 | 13 | 1_268 | 428.6666666666667 | 457.0 | Region | ARE binding |
Top |
Fusion Protein Structures |
| PDB and CIF files of the predicted fusion proteins * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
| Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
| PDB file >>>2_ALB_74270123_EXOSC9_122737927_ranked_0.pdb | ALB | 74270123 | 74270123 | ENST00000243498 | EXOSC9 | chr4 | 122737927 | + | 52 |
Top |
pLDDT score distribution |
| pLDDT score distribution of the predicted wild-type structures of two partner proteins from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
ALB_pLDDT.png  |
EXOSC9_pLDDT.png  |
| pLDDT score distribution of the predicted fusion protein structures from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
 |
Top |
Ramachandran Plot of Fusion Protein Structure |
| Ramachandran plot of the torsional angles - phi (φ)and psi (ψ) - of the residues (amino acids) contained in this fusion protein peptide. |
| Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
| Gene | PPI interactors |
| Protein-protein interactors based on sequence similarity (STRING) |
| Gene | STRING network |
| ALB | |
| EXOSC9 |
| - Retained interactions in fusion protein (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost interactions due to fusion (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to ALB-EXOSC9 |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ALB-EXOSC9 |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies